Maternity Services, Guy's and St. Thomas' Hospital NHS Trust, St. Thomas' Hospital.
School of Life Course Sciences, King's College London, London, UK.
Blood Press Monit. 2021 Oct 1;26(5):380-384. doi: 10.1097/MBP.0000000000000552.
To validate the BPro blood pressure (BP) wrist device for use in pregnancy and preeclampsia according to the Universal Standard protocol.
BP was measured sequentially in 45 pregnant women (including 15 with preeclampsia, 15 with gestational hypertension and 15 who remained normotensive) alternating between a mercury sphygmomanometer and BPro device.
The BPro is accurate in pregnancy with a mean device-observer difference of -1.7 ± 6.1 and 0.1 ± 4.6 mmHg for SBP and DBP, respectively. In women with preeclampsia, BPro also met the validation criteria for the Universal Standard protocol with a mean device-observer difference of -2.7 ± 7.1 and 0.3 ± 4.7 mmHg for SBP and DBP, respectively. However, the number of absolute BP differences within 5 mmHg was considerably fewer in those with preeclampsia when compared to the other two subgroups.
The BPro device can be recommended for BP measurement in pregnancy but should be used with caution in those with confirmed preeclampsia.
根据通用标准协议，验证 BPro 腕式血压（BP）设备在妊娠和子痫前期中的使用。
在 45 名孕妇中（包括 15 名子痫前期患者、15 名妊娠期高血压患者和 15 名血压正常的患者），分别用汞柱血压计和 BPro 设备交替测量血压。
BPro 在妊娠中是准确的，收缩压和舒张压的设备-观察者平均差异分别为-1.7±6.1 和 0.1±4.6mmHg。在子痫前期患者中，BPro 也符合通用标准协议的验证标准，收缩压和舒张压的设备-观察者平均差异分别为-2.7±7.1 和 0.3±4.7mmHg。然而，与其他两个亚组相比，子痫前期患者的绝对血压差值在 5mmHg 内的数量明显较少。
BPro 设备可推荐用于妊娠期间的血压测量，但在确诊子痫前期患者中应谨慎使用。
